Zwitterionic amino acid polymers (ZAPs) exhibit biocompatibility
and recognition capability for amino acid transporters (AATs) overexpressed
on cancer cells. They are potential cancer-targeting ligands in nanoparticle-based
nanomedicines utilized in cancer chemotherapy. Here, a poly(glutamine
methacrylate) (pGlnMA)-grafted core-crosslinked particle (pGlnMA-CCP)
is prepared through the formation of nanoemulsions stabilized using
amphiphilic block copolymers comprising pGlnMA as the hydrophilic
block. The chain conformation of the grafted polymer and the particle
structure of pGlnMA-CCP are precisely elucidated by dynamic light
scattering, X-ray scattering, and transmission electron microscopy.
pGlnMA-CCP demonstrates active cellular uptake and deep penetration
behaviors for cancer cells and spheroids, respectively, via an AAT-mediated
mechanism. The in vivo pharmacokinetics of pGlnMA-CCP
is practically comparable to those of a CCP covered with poly(polyethylene
glycol methacrylate) (pPEGMA), which inhibits protein adsorption and
prolongs blood retention, implying that the biocompatible properties
of pGlnMA are similar to those of pPEGMA. Furthermore, pGlnMA-CCP
accumulates in cancer tissues at a higher level than that of pPEGMA
systems. The results demonstrate that the properties of cancer targetability,
tumor permeability, efficient tumor accumulation, and biocompatibility
can be obtained by grafting pGlnMA onto nanoparticles, suggesting
a high potential of pGlnMA as a ligand for cancer-targeting nanomedicines.